Miguel Cid

Miguel Cid

Auto-generated profile, based on publicly available information

Miguel Cid

Alternative Gene Expression S.L. (ALGENEX). Centro Empresarial. Parque Científico y Tecnológico de la UPM, Campus Montegancedo, 28223 Pozuelo de Alarcón, Madrid Spain

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2009 in Computers and Electronics in Agriculture
Verified
Journal Article
Closed access
ESE. Sarria
E. Sarria
MCM. Cid
M. Cid
Elisa GarzoElisa Garzo
Elisa Garzo
Alberto FereresAlberto Fereres
Alberto Fereres

1 December 2007 in European Journal of Plant Pathology
Verified
Journal Article
Closed access
PDF file
CCCristina Cabaleiro
Cristina Cabaleiro
CCCarolina Couceiro
Carolina Couceiro
SPSonia Pereira
Sonia Pereira
MCMiguel Cid
Miguel Cid
MBMartín Barrasa
Martín Barrasa
ASAntonio Segura
Antonio Segura

1 June 2010 in Journal of Economic Entomology
Verified
Journal Article
Closed access
MCM. Cid
M. Cid
SPS. Pereira
S. Pereira
CCC. Cabaleiro
C. Cabaleiro
ASA. Segura
A. Segura
The citrus mealybug, Planococcus citri (Risso) (Hemiptera: Pseudococcidae), is the main grapevine pest in vineyards in some countries, such as Spain and Brazil. In Galician vineyards (northwestern Spain), mealybug population levels are low because the accumulated degree-days are lower than in other grapevine-growing areas. The main problem caused by mealybugs is the transmission of viruses, even at low infestation levels. The active period of citrus mealybug in the study vineyard lasted from July until December, with an important movement peak at the end of July and August and a lower peak in November. The mealybug mainly moved upward along arbor-trained plants, and there were no important downward movements at the end of the season as has been described for other grapevine mealybugs. The mealybugs were normally restricted to the woody organs and were only present on leaves, branches, and green canes (always close to woody parts) in plants with high infestations. The movement of mealybugs between plants does not seem to take place by contact between green organs. Passive aerial transport and movement of pruning remains may play an important role in mealybug movement and thus in spread of the virus. The number of mealybugs carrying Grapevine leafroll-associated virus 3 (GLRaV-3) was found to represent 75% of mealybugs caught in a GLRaV-3 infected vineyard.

16 September 2011 in Journal of Applied Phycology
Verified
Journal Article
Closed access
PDF file
MTManuel García Tasende
Manuel García Tasende
MCMiguel Cid
Miguel Cid
MFM. Isabel Fraga
M. Isabel Fraga

26 August 2012 in Journal of Applied Phycology
Verified
Journal Article
Closed access
PDF file
MTManuel Garcia Tasende
Manuel Garcia Tasende
MCMiguel Cid
Miguel Cid
MFM. Isabel Fraga
M. Isabel Fraga

1 January 2020 in Journal of Biotechnology
Verified
Journal Article
Open access
JEJosé Escribano
José Escribano
MCMiguel Cid
Miguel Cid
EREdel Reytor
Edel Reytor
CACarmen Alvarado
Carmen Alvarado
MNMaría C. Nuñez
María C. Nuñez
RDRomy M. Dalton
Romy M. Dalton
The baculovirus vector expression system (BEVS) combines cultured insect cells and genetically modified Autographa californica nuclear polyhedrosis virus (AcMNPV)-derived baculovirus vectors. This expression system has been widely used for the expression of hundred of proteins for more than 30 years, existing commercial products manufactured at large scale by this methodology, mainly subunit vaccines. At an industrial scale, insect cells, as any other cultured cells, require artificial media and a strict control of environmental sterile conditions in the complex and expensive bioreactors. Here we describe an efficient alternative to produce recombinant biologics using the versatile and productive baculovirus vectors. It consists in natural biocapsules (pupae from Trichoplusia ni (Hübner) Lepidoptera), containing millions of insect cells in perfect physiological conditions, ready to be programmed by a genetically modified AcMNPV-derived baculovirus vector to produce large quantities of any recombinant protein. This technology, denominated CrisBio, has been tested to produce dozens of proteins, reaching productivities on the range of milligrams per infected pupa, that can be translated into dozens of vaccine doses, for example. The biologics production by CrisBio was industrialized with the design of both insect rearing and pupae storage single-use plastic devices, compatible with machines specifically designed for the automation of pupae manipulation and inoculation. These devices and machines reduce manual operations, increase batches consistency and facilitate the scaled production of any recombinant protein. As a mode of examples, the productivity in CrisBio technology platform of two virus-like particle (VLP) vaccine antigens is described in this work.